Regeneron CEO on first-ever FDA approved gene therapy to restore hearing

Regeneron CEO Leonard Schleifer joins 'Squawk Box' to discuss the FDA's approval of the company's hearing loss drug Otarmeni, a gene therapy designed to treat and potentially reverse a rare form of inherited hearing loss in children, why the company is providing the therapy for free in the U.S., and more.